Advanced searches left 3/3

Chest Pain - DOAJ

Summarized by Plex Scholar
Last Updated: 19 November 2022

* If you want to update the article please login/register

Chest Pain in the Cancer Patient

Chest pain is one of the most common presenting signs in patients seeking medical attention. Risk assessment tools and scores have aided in prompt diagnosis and optimal treatment in these patients; however, it is also unknown if a standardized approach will adequately triage chest pain in cancer patients and survivors. This paper explores the root causes of chest pain in cancer patients, with an emphasis on how their treatment may differ from that of non-cancer patients with chest pain.

Source link: https://doi.org/10.15420/ecr.2021.45


Role of Coronary CT Angiography in the Evaluation of Acute Chest Pain and Suspected or Confirmed Acute Coronary Syndrome

Advances in CT technology have resulted in improved imaging of the coronary anatomy in patients with stable coronary artery disease in patients with stable coronary artery disease, according to coronary CT angiography. CCTA may have a role in high risk patients, such as those evaluated in the emergency room with acute chest pains, according to recent reports. CDCTA has been used in low-risk patients with acute chest pain, according to evidence that so far. The excellent results of CCTA in detecting obstructive coronary artery disease in patients with ACS are detailed, as well as a characterization of the dangers of using CCTA in this setting.

Source link: https://doi.org/10.15420/usc.2021.30


Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain

Elevation of chest pain patients presenting to emergency departments is common in chest pain patients with elevated troponin levels not related to type 1 myocardial infarction. Methods We calculated the hs-CTnI or hs-CTnT ratio in 888 chest pain patients with hs-cTnI or hs-cTnT values at 2 hours from presentation, with a 99% percentile at 2 hours from display. Conclusions The median hs-CTN I/T ratio in type 1 MI patients was 3. 45, 1. 18 in type 2 MI patients, and 0. 67 in patients without MI. In adjusted results, the hs-cTn I/T ratio provided good discrimination of type 1 MI from type 2 MI from type 2 MI, and was attributed to type 1 MI from type 2 MI from type 2 MI, and was associated with type 1 MI. Conclusions The hs-cTn I/T ratio seems to be a good predictor of type 1 MI and its discrimination in chest pain patients with elevated hs-cTn.

Source link: https://doaj.org/article/14d1cf83b43149d5bae47e0b723505da


Acceleration of chest pain center construction and improvements for the treatment of acute myocardial infarction in China

In China, acute coronary syndrome diagnosis and the drafting of modern treatment guidelines lags behind those in other developed countries. The Chinese Medical Association, the Chinese Association of Cardiovascular Health, and the Cardiovascular Health Alliance have joined together to accelerate the construction of China Chest Pain Centers and tighter certification requirements. We recommend the establishment of 40 chest pain center demonstration bases in China between 2016 and 2018. We recommend the establishment of 40 chest pain center demonstration bases by providing information and assistance to 2500 hospitals in order to meet the goals of promotion, construction, and certification of 1000 chest pain centers between 2016 and 2018.

Source link: https://doi.org/10.4103/2470-7511.248350


The national chest pain centers program: Monitoring and improving quality of care for patients with acute chest pain in China

Background: The National Chest Pain Centers Program is the most comprehensive, hospital-based, multifaceted quality improvement initiative, aimed at patients with acute chest pain. Objectives: This research was designed to investigate the success and usage of the chest pain center accreditation and identify causes that may impede its implementation in local settings. Conclusions: We recommend in this report that chest pain center accreditation can be implemented more effectively, which will increase the quality of care for patients with acute chest pain, as well as promote the sustainable growth of chest pain centers.

Source link: https://doi.org/10.4103/2470-7511.327239


Advantage of Using of High-Sensitivity Troponin I Compared to Conventional Troponin I in Shortening Time to Rule out/in Acute Coronary Syndrome in Chest Pain Patients Presenting to the Emergency Department

Objectives and Objectives: Using high-sensitivity troponin I and conventional troponin I in patients presenting to the emergency department with chest pain, we wanted to compare the time to diagnosis for acute coronary syndromes. This was an observational prospective study involving patients presenting to the ED of Santu2019Andrea Hospital University La Sapienza in Rome with chest pain from January to December 2014. A total of 393 patients in the United States were found to have acute coronary syndrome in ED. Conclusions: The use of hsTnI in patients with chest pain was linked to a reduced time to ruling in/out ACS, and, in turn, hsTnI should be used more frequently over TnI for more accurate identification of ACS with benefits for patients and related costs.

Source link: https://doi.org/10.3390/medicina58101391


Congenital Pericardial Agenesis presenting as non-specific chest pain: A Case Report

Congenital absence of pericardium is an extremely rare disease with a prevalence of 0. 002%-0. 004%. Pericardial agenesis is often misdiagnosed due to the lack of symptoms and medical knowledge. This should be regarded as a different diagnosis of exertional chest pains.

Source link: https://doi.org/10.1016/j.radcr.2022.08.075


Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry

GoalAlthough aninvasive strategy has been suggested within 24 h for patients with non-ST-segment elevation myocardial infarction, the correct time of the intervention remains uncertain. Patients with NSTEMI from the Evaluation and Management of Patients with Acute ChesT pain in China registry between January 2016 and September 2017 were included in our study. ResultsAccording to this report, a total of 969 patients with NSTEMI from the EMPACT Registry were eligible for the trial. Patients who received CAG had a lower risk of MACEs and mortality than those who did not receive CAG. However, no statistically significant difference was found between the early and delayed CAG groups in terms of MACEs and mortality.

Source link: https://doi.org/10.3389/fcvm.2022.1000554

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions